Why is the trial being carried out?
Each year over 30,000 people’s hearts suddenly stop beating in communities around the UK (a condition known as
out-of-hospital cardiac arrest). Drugs such as adrenaline are widely used to treat cardiac arrest as they are very effective at restarting the heart. The sooner these drugs are given the better the chance is that they will be successful. However, for many people drugs are given too late to save them. This partly explains why less than one in ten people survive an out of hospital cardiac arrest.

Currently, paramedics normally give drugs into a vein. The problem with this is that it can take several critical minutes to get lifesaving drugs into a vein. A new, faster way of giving drugs is to put a small needle into an arm or leg bone. This allows drugs to be injected directly into the rich blood supply found in the bone marrow. We do not currently know which is the best approach as none of the existing research is good enough to help paramedics decide how best to treat people with cardiac arrest.

When doctors, nurses and paramedics do not know the best way to provide a treatment it is common to do a study. In this study those enrolled are put in to two groups – half received drug treatment through a vein and half received it through a bone. At the end of the study the results will be compared to see if one is better. To try to make sure the groups are the same to start with, each patient is put into a group by chance (randomly) through a process called randomisation.

To learn more about what is a cardiac arrest please click here.Link opens in a new window

Aim of the study
The aim of the study is to find out if giving drugs through a vein or into the bone is the most effective way to treat
someone when their heart suddenly stops working and whether it makes a difference to how well people recover after
cardiac arrest. We plan to test whether injecting drugs into the vein or the bone is most effective.

Who will take part in the study?
NHS paramedics in England and Wales will recruit approximately 15,000 patients in to the study from the UK only.

Patients will be recruited in to the study if they have a cardiac arrest outside of hospital, in areas where ambulance services are taking part in the study. Patients who are pregnant, under the age of 18 or cannot be given drugs because the NHS paramedic cannot access their vein will not be included.

Trial OverviewLink opens in a new window

About cardiac arrestLink opens in a new window

Support for the trialLink opens in a new window

Information for ambulance research teamsLink opens in a new window

Information for the publicLink opens in a new window

FAQsLink opens in a new window

Trial ResourcesLink opens in a new window

News and eventsLink opens in a new window

PublicationsLink opens in a new window

Contact the teamLink opens in a new window

Enquiries:

Please direct all enquiries for the PARAMEDIC-3 trial team.

Telephone: 07385029213
Email: paramedic3@warwick.ac.uk